We are a Specialty Pharmaceutical Company
with a Focus in Pain and Addiction

Product Pipeline

Bio Delivery Sciences

Onsolis BUNAVAIL BELBUCA Clonidine Topical Gel

Technology Platform

BEMA® Technology

A small, dissolvable polymer film for application to mucosal membranes (inner lining of cheek) which allows for transmucosal delivery of drugs.

 

Get the latest details on our products and services.

Top News

BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule
SAMHSA Reports 1,665 Clinicians Granted Waivers at the Increased Limit as of This Week


BioDelivery Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference



BioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL
New contracts improve BUNAVAIL formulary status and give BUNAVAIL access to approximately 200,000 additional prescriptions for buprenorphine products for opioid dependence annually


BioDelivery Sciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference and the 7th Annual Credit Suisse Small and Mid Cap Conference



BioDelivery Sciences Provides Corporate Update and Reports Second Quarter 2016 Financial Results
BDSI targeting BUNAVAIL® profitability by end of 2017 following commercial restructuring, managed care wins and improved operating margins